- Investing Ideas
- Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
Chugai Pharmaceutical
Market Cap: JP¥15.0t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥9,317.00
7D
-2.1%
1Y
36.4%
Daiichi Sankyo Company
Market Cap: JP¥5.1t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,949.50
7D
3.6%
1Y
-16.5%
Takeda Pharmaceutical
Market Cap: JP¥9.1t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥5,804.00
7D
1.5%
1Y
28.5%